MarshaKay(Browning)FearingMDMD, MPH, MMSc. (She/Her)

PubMed

• 4 citations
  Case records of the Massachusetts General Hospital. Case 12-2011. A 9-month-old boy with acute liver failure.
  Marsha K. Fearing, Esther J. Israel, Inderneel Sahai, Otto Rapalino, Mikhail Lisovsky> ;The New England Journal of Medicine. 2011 Apr 20
• Macroautophagy is defective in mucolipin-1-deficient mouse neurons.
  Curcio-Morelli, C., Charles, F.A., Micsenyi, M.C., Cao, Y., Venugopal, B., Browning, M.F., Dobrenis, K., Cotman, S.L., Walkley, S.U., Slaugenhaupt, S.A.> ;Neurobiol Dis. 2010 Nov
• Parents' decision-making in newborn screening: opinions, choices, and information needs.
  Lipstein, E.A., Nabi, E., Perrin, J.M., Luff, D., Browning, M.F., Kuhlthau, K.A.> ;Pediatrics. 2010 Oct
• Ocular manifestations of Fabry disease within in a single kindred.
  Morier, A.M., Minteer, J., Tyszko, R., McCann, R., Clarke, M.V., Browning, M.F.> ;Optometry. 2010 Sep
• Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay.
  Wi?niowiecka-Kowalnik, B., Nesteruk, M., Peters, S. U., Xia, Z., Cooper, M. L., Savage, S., Amato, R. S., Bader, P., Browning, M. F., Haun, C. L., Duda, A. W., Cheung,...> ;Am J Med Genet B Neuropsychiatr Genet. 2010 Jul
• Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency.
  Lipstein, E.A., Vorono, S., Browning, M.F., Green, N.S., Kemper, A.R., Knapp, A.A., Prosser, L.A., Perrin, J.M.> ;Pediatrics. 2010 May
• An evidence development process for newborn screening.
  Perrin, J.M., Knapp, A.A., Browning, M.F., Comeau, A.M., Green, N.S., Lipstein, E.A., Metterville, D.R., Prosser, L., Queally, D., Kemper, A.R.> ;Genet Med. 2010 Mar
• Functional multimerization of mucolipin channel proteins.
  Curcio-Morelli, C., Zhang, P., Venugopal, B., Charles, F.A., Browning, M.F., Cantiello, H.F., Slaugenhaupt, S.A.> ;J Cell Physiol. 2010-02-01
• Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.
  Venugopal, B., Browning, M.F., Curcio-Morelli, C., Varro, A., Michaud, N., Nanthakumar, N., Walkley, S.U., Pickel, J., Slaugenhaupt, S.A.> ;Am J Hum Genet. 2007 Nov
• Fetal fatty acid oxidation defects and maternal liver disease in pregnancy.
  Browning, M.F., Levy, H.L., Wilkins-Haug, L.E., Larson, C., Shih, V.E.> ;Obstet Gynecol. 2006 Jan
• 31 citations
  Expanded newborn screening.
  Marsha K Fearing, Deborah Marsden> ;Pediatric Annals. 2003 Aug 1
• 25 citations
  Expanded newborn screening using tandem mass spectrometry.
  Marsha K. Fearing, Harvey L. Levy> ;Advances in Pediatrics. 2003 Jan 1
• Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects.
  Browning, M. F., Larson, C., Strauss, A., Marsden, D. L.> ;J Inherit Metab Dis. 2005
• Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper.
  Olivova, P., van der Veen, K., Cullen, E., Rose, M., Zhang, X. K., Sims, K. B., Keutzer, J., Browning, M. F.> ;Clin Chim Acta. 2009 May
• Join now to see all